Future Fund LLC’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,632
Closed -$320K 30
2023
Q3
$320K Sell
1,632
-123
-7% -$25.3K 0.89% 16
2023
Q2
$369K Buy
1,755
+501
+40% +$99.7K 3.51% 13
2023
Q1
$253K Sell
1,254
-208
-14% -$47.1K 0.83% 14
2022
Q4
$319K Buy
1,462
+52
+4% +$11.4K 1.09% 9
2022
Q3
$277K Sell
1,410
-54
-4% -$11.7K 0.56% 10
2022
Q2
$313K Buy
1,464
+146
+11% +$35.7K 0.71% 8
2022
Q1
$374K Sell
1,318
-22
-2% -$6.78K 0.43% 12
2021
Q4
$505K Buy
+1,340
New +$521K 0.44% 7

Other funds holding CRL

Future Fund LLC's CRL Position: Q4 2023 in Review

Future Fund LLC sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 1,632 shares — an estimated $320K sold.

Future Fund LLC first reported a position in CRL in Q4 2021 and held it in 8 quarters. The position peaked at $505K in Q4 2021. 633 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Future Fund LLC reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • Future Fund LLC sold 1,632 Charles River Laboratories shares in Q4 2023, an estimated $320K.
  • Future Fund LLC first reported a position in Charles River Laboratories in Q4 2021 and held it in 8 quarters.
  • Future Fund LLC's Charles River Laboratories position peaked at $505K in Q4 2021.
  • 633 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Future Fund LLC's 13F filing for Q4 2023, filed 14 Feb 2024.